EndoChoice Raises $96M On NYSE

June 8, 2015 | The Israeli-American medical equipment company EndoChoice raised $96 million in its offering on the New York Stock Exchange at a company value of $366 million, after money. The offering, which was valued lower than expected, was led by JP Morgan and Bank of America. EndoChoice was founded in 2008 by Will Parks and Mark G. Gilreath and is headquartered in Alpharetta, Georgia.